XML 133 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Compensation Plans and Stock Based Compensation (Tables)
12 Months Ended
Dec. 28, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock based compensation expense and allocation by share based payment award
Stock-based compensation expense and the related income tax benefit recognized in connection with stock options, restricted stock and the Employee Stock Purchase Plan, or ESPP, during fiscal 2013, 2012 and 2011 were as follows:
 
2013
 
2012
 
2011
 
(In thousands)
Stock options
$
13,100

 
$
8,752

 
$
8,685

Restricted stock
49,019

 
34,838

 
30,815

ESPP
4,166

 
3,971

 
4,088

Total stock-based compensation expense
$
66,285

 
$
47,561

 
$
43,588

 
 
 
 
 
 
Income tax benefit
$
16,236

 
$
12,453

 
$
1,406

Stock based compensation expense and allocation by cost
Stock-based compensation expense is reflected throughout Cadence's costs and expenses during fiscal 2013, 2012 and 2011 as follows:
 
2013
 
2012
 
2011
 
(In thousands)
Cost of product and maintenance
$
1,596

 
$
1,317

 
$
1,468

Cost of services
2,321

 
1,889

 
2,105

Marketing and sales
15,642

 
10,193

 
10,356

Research and development
32,999

 
21,516

 
18,561

General and administrative
13,727

 
12,646

 
11,098

Total stock-based compensation expense
$
66,285

 
$
47,561

 
$
43,588

Fair value of options granted and the weighted-average assumptions
The weighted-average grant date fair value of options granted and the weighted-average assumptions used in the model for fiscal 2013, 2012 and 2011 were as follows:
 
2013
 
2012
 
2011
Dividend yield
None

 
None

 
None

Expected volatility
40.0
%
 
46.4
%
 
44.9
%
Risk-free interest rate
0.86
%
 
0.79
%
 
2.18
%
Expected term (in years)
4.7

 
4.6

 
4.7

Weighted-average fair value of options granted
$
4.93

 
$
4.57

 
$
3.93

Summary of changes in stock options outstanding under equity incentive plans
A summary of the changes in stock options outstanding under Cadence's equity incentive plans during fiscal 2013 is presented below:
 
 
 
Weighted-
Average
 
Weighted-
Average
Remaining
Contractual
Terms
 



Aggregate
Intrinsic
 
Shares
 
Exercise Price
 
(Years)
 
Value
 
(In thousands)
 
 
 
 
 
(In thousands)
Options outstanding as of December 29, 2012
19,278

 
$
10.71

 
 
 
 
Acquired options
1,495

 
$
2.46

 
 
 
 
Granted
1,042

 
$
14.21

 
 
 
 
Exercised
(2,982
)
 
$
9.25

 
 
 
 
Canceled and forfeited
(1,358
)
 
$
15.88

 
 
 
 
Options outstanding as of December 28, 2013
17,475

 
$
10.06

 
3.4
 
$
80,673

Options vested as of December 28, 2013
14,104

 
$
10.27

 
2.8
 
$
64,423

Options vested as of, and expected to vest after, December 28, 2013
17,462

 
$
10.06

 
3.4
 
$
80,632

Intrinsic value of and cash received from options exercised
The total intrinsic value of and cash received from options exercised during fiscal 2013, 2012 and 2011 was:
 
2013
 
2012
 
2011
 
(In thousands)
Intrinsic value of options exercised
$
15,114

 
$
11,493

 
$
7,255

Cash received from options exercised
$
27,569

 
$
19,119

 
$
6,478

Stock-based compensation expense related to performance-based restricted stock grants
Stock-based compensation expense related to performance-based restricted stock grants for fiscal 2013, 2012 and 2011 was as follows:
 
2013
 
2012
 
2011
 
(In thousands)
Stock-based compensation expense related to performance-based grants
$
4,340

 
$
3,230

 
$
2,174

Summary of the changes in restricted stock outstanding under Cadence's equity incentive plans
A summary of the changes in restricted stock outstanding under Cadence's equity incentive plans during fiscal 2013, is presented below:
 
 
 
Weighted-
Average Grant Date
 
Weighted-
Average
Remaining
Vesting
Terms
 



Aggregate
Intrinsic
 
Shares
 
Fair Value
 
(Years)
 
Value
 
(In thousands)
 
 
 
 
 
(In thousands)
Unvested shares as of December 29, 2012
9,444

 
$
10.40

 
 
 
 
Granted
5,306

 
$
15.30

 
 
 
 
Vested
(4,089
)
 
$
9.87

 
 
 
 
Forfeited
(548
)
 
$
11.77

 
 
 
 
Unvested shares as of December 28, 2013
10,113

 
$
13.11

 
1.1
 
$
139,761

Unvested shares expected to vest after December 28, 2013
9,418

 
$
13.08

 
1.1
 
$
130,131

Total fair value of restricted stock awards that vested
The total fair value realized by employees upon vesting of restricted stock during fiscal 2013, 2012 and 2011 was:
 
2013
 
2012
 
2011
 
(In thousands)
Fair value of restricted stock realized upon vesting
$
58,091

 
$
48,249

 
$
43,756

Weighted-average grant date fair value of purchase rights granted under ESPP and weighted average assumptions used in model
The weighted-average grant date fair value of purchase rights granted under the ESPP and the weighted-average assumptions used in the model for fiscal 2013, 2012 and 2011 were as follows:
 
2013
 
2012
 
2011
Dividend yield
None

 
None

 
None

Expected volatility
25.7
%
 
31.4
%
 
38.4
%
Risk-free interest rate
0.09
%
 
0.12
%
 
0.17
%
Expected term (in years)
0.5

 
0.5

 
0.5

Weighted-average fair value of options granted
$
3.21

 
$
2.78

 
$
2.48

Shares of common stock issued under Employee Stock Purchase Plan
Shares of common stock issued under the ESPP for fiscal 2013, 2012 and 2011 were as follows:
 
2013
 
2012
 
2011
 
(In thousands, except per share amounts)
Cadence shares purchased under the ESPP
1,382

 
1,548

 
2,029

Cash received for the purchase of shares under the ESPP
$
15,088

 
$
13,568

 
$
13,236

Weighted-average purchase price per share
$
10.91

 
$
8.77

 
$
6.52

Summary of common stock reserved for future issuance
As of December 28, 2013, Cadence had reserved the following shares of authorized but unissued common stock for future issuance:
 
Shares
 
(In thousands)
Employee equity incentive plans*
32,600

2015 Warrants
46,382

2013 Warrants
6,830

Employee stock purchase plans
9,869

Directors stock option plans*
2,475

    Total
98,156

_____________
* Includes shares reserved for: (i) issuance upon exercise of future option grants, (ii) issuance upon vesting of future restricted stock grants, (iii) outstanding but unexercised options to purchase common stock, or (iv) unvested restricted stock units.